Russia approves Novartis' fingolimod

The Russian Federal Service on Surveillance in Healthcare and Social Development approved Gilenya fingolimod from Novartis AG (NYSE:NVS; SIX:NOVN) to treat relapsing-remitting multiple sclerosis (RRMS...